NCT03976557

BIP CVC in Access Center at Danderyd Hospital, Stockholm, Sweden

Implementation and Evaluation of BIP CVC in Access Center at Danderyd Hospital, Stockholm, Sweden. Study Protocol

• Status: Terminated
• Phase: N/A
• Study type: Interventional
• Enrollment: 19 (actual)
• Sponsor: Bactiguard AB · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Primary objective of the study is to establish the incidence of all any catheter related complications in BIP CVC and standard CVC groups in patients requiring CVC. (CVC - Central Venous Catheter; BIP - Bactiguard Infection Protection)

Detailed description

Catheter related complications include CRBSI, CRI, Local CVC infection, need to exchange of CVC due to suspected CRI/CRBSI or thrombosis, stop / slower flow in any CVC lumen, local thrombosis, device malfunctions / technical catheter problems, device related adverse events. (CRBSI - Catheter Related Blood Stream Infection; CRI - Catheter Related Infection)

Conditions

• Vascular Access Complication
• Catheter-Related Infections
• Catheter Thrombosis
• Catheter Blockage
• Catheter Complications
• Catheter Site Discomfort
• Catheter Bacteraemia

Interventions

Type	Name	Description
DEVICE	BIP CVC	Central venous access with noble metal coated CVC
DEVICE	Standard CVC	Central venous access with standard uncoated CVC

Timeline

• Start date: 2019-04-11
• Primary completion: 2019-12-18
• Completion: 2019-12-18
• First posted: 2019-06-06
• Last updated: 2021-01-22

Locations

1 site across 1 country: Sweden